Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling (Q37238527)
Jump to navigation
Jump to search
scientific article published on 26 June 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling |
scientific article published on 26 June 2013 |
Statements
1 reference
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling (English)
1 reference
William E Grizzle
1 reference
Yaguang Xi
1 reference
Nan Li
1 reference
Heather N Tinsley
1 reference
Evrim Gurpinar
1 reference
Bernard D Gary
1 reference
Bing Zhu
1 reference
Yonghe Li
1 reference
Xi Chen
1 reference
Adam B Keeton
1 reference
Ashraf H Abadi
1 reference
Mary P Moyer
1 reference
Wen-Chi Chang
1 reference
Margie L Clapper
1 reference
Gary A Piazza
1 reference
26 June 2013
1 reference
1 reference
1848-1859
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference